Loading…
Fairchem Organics (FAIRCHEMOR)₹701.40+5.26%Specialty Chemicals
In the Jun 2026 quarter (standalone), Fairchem Organics reported sales of ₹176 Cr, up 34.2% from Jun 2025, and net profit of ₹9.98 Cr, up 908.1% year on year. For the year to Mar 2026, sales were ₹460 Cr and net profit ₹5.99 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152 | 148 | 161 | 165 | 139 | 114 | 121 | 131 | 112 | 99.99 | 117 | 176 |
| Expenses | 135 | 128 | 142 | 143 | 130 | 106 | 116 | 126 | 107 | 95.74 | 109 | 158 |
| Operating Profit | 16.92 | 19.92 | 18.94 | 21.91 | 8.96 | 7.96 | 3.98 | 4.98 | 3.99 | 3.98 | 7.97 | 17.93 |
| OPM % | 11.0% | 13.0% | 12.0% | 13.0% | 6.0% | 7.0% | 3.7% | 4.0% | 3.8% | 4.2% | 7.0% | 10.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | 1.01 | 0.00 |
| Interest | 1.01 | 1.01 | 1.01 | 0.99 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 |
| Depreciation | 1.99 | 1.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Profit before tax | 14.01 | 16.98 | 15.99 | 18.99 | 5.01 | 4.99 | 1.01 | 1.99 | 0.99 | 0.00 | 4.99 | 13.99 |
| Tax % | 26.0% | 26.0% | 26.0% | 26.0% | 27.0% | 25.0% | 47.0% | 27.0% | 35.0% | −48.0% | 22.0% | 27.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | 0.00 | 0.00 |
| Net Profit | 9.99 | 11.98 | 11.98 | 13.97 | 3.99 | 3.99 | 0.99 | 0.99 | 0.99 | 0.00 | 3.99 | 9.98 |
| EPS (Rs) | 7.93 | 9.50 | 9.06 | 10.67 | 3.09 | 2.71 | 0.46 | 0.91 | 0.60 | −0.09 | 2.94 | 7.97 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 647 | 621 | 538 | 460 | 505 |
| Expenses | 257 | 327 | 536 | 575 | 552 | 494 | 437 | 469 |
| Operating Profit | 48.83 | 68.73 | 105 | 71.71 | 66.78 | 42.83 | 21.93 | 33.87 |
| OPM % | 16.0% | 17.0% | 16.0% | 11.0% | 11.0% | 8.0% | 4.7% | 6.7% |
| Other Income | 6.01 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 |
| Interest | 7.01 | 6.99 | 7.01 | 5.99 | 4.01 | 4.01 | 4.01 | 5.04 |
| Depreciation | 5.98 | 6.98 | 6.97 | 7.97 | 8.97 | 10.96 | 10.95 | 11.96 |
| Profit before tax | 41.98 | 55.95 | 91.04 | 59.01 | 54.97 | 30.01 | 6.99 | 19.97 |
| Tax % | 18.0% | 24.0% | 26.0% | 26.0% | 26.0% | 27.0% | 24.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 | −1.01 |
| Net Profit | 34.93 | 41.91 | 67.91 | 43.90 | 39.95 | 21.97 | 5.99 | 14.96 |
| EPS (Rs) | — | 32.72 | 52.27 | 33.50 | 31.20 | 16.92 | 4.41 | 11.42 |
| Dividend payout % | 0.0% | 11.0% | 25.1% | 22.0% | 24.0% | 44.1% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13.04 | 13.05 | 13.04 | 13.05 | 13.05 | 13.04 |
| Reserves | 127 | 156 | 220 | 247 | 278 | 290 | 251 |
| Borrowings | 67.07 | 57.01 | 62.07 | 49.97 | 7.01 | 62.99 | 83.98 |
| Other Liabilities | 25.12 | 33.16 | 30.14 | 33.16 | 37.18 | 37.18 | 44.21 |
| Total Liabilities | 220 | 260 | 325 | 343 | 335 | 403 | 392 |
| Fixed Assets | 126 | 126 | 142 | 157 | 192 | 202 | 197 |
| CWIP | 8.98 | 28.96 | 41.96 | 34.97 | 5.99 | 11.99 | 17.96 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 83.16 | 103 | 141 | 151 | 137 | 189 | 176 |
| Inventories | 34.88 | 44.88 | 69.80 | 79.82 | 69.86 | 87.80 | 91.79 |
| Trade receivables | 38.16 | 47.20 | 62.23 | 63.24 | 57.19 | 86.27 | 68.24 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 |
| Total Assets | 220 | 260 | 325 | 343 | 335 | 403 | 392 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 31.03 | 40.05 | 40.01 | 50.02 | 74.10 | −17.03 | 42.01 |
| Cash from investing activity | −23.93 | −22.92 | −33.85 | −13.96 | −17.93 | −25.89 | −13.95 |
| Cash from financing activity | −6.99 | −16.98 | −5.99 | −34.99 | −56.98 | 41.95 | −27.95 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 30.44 | 23.21 | 34.70 | 14.78 | 18.18 | 26.20 | 15.41 |
| Free cash flow | 1.01 | 17.02 | 6.01 | 35.01 | 56.99 | −42.03 | 28.03 |
| CFO / OP % | 82.0% | 77.0% | 60.0% | 88.0% | 131.0% | −15.0% | 180.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 46 | 44 | 36 | 36 | 34 | 59 | 55 |
| Inventory days | 64 | 63 | 56 | 60 | 56 | 86 | 95 |
| Days payable | 13 | 16 | 8 | 9 | 12 | 9 | 13 |
| Cash conversion cycle | 97 | 90 | 84 | 88 | 79 | 136 | 138 |
| Working capital days | 14 | 43 | 40 | 46 | 63 | 68 | 53 |
| ROCE % | — | 30.0% | 38.0% | 22.0% | 19.0% | 10.0% | 3.0% |
For the Jun 2026 quarter, Fairchem Organics reported sales of ₹176 Cr, up 34.2% year on year and net profit of ₹9.98 Cr, up 908.1% year on year. The operating margin was 10.0%.
Fairchem Organics' sales for the year to Mar 2026 were ₹460 Cr; over the last twelve months they were ₹505 Cr.
Net profit for the year to Mar 2026 was ₹5.99 Cr, and ₹14.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹11.42.
Fairchem Organics reported borrowings of ₹83.98 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.
Cash from operations was ₹42.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹28.03 Cr.